Safety and immunogenicity of a recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in Sierra Leone: a single-centre, randomised, double-blind, placebo-controlled, phase 2 trialFengcai Zhu, Wei Chen, Yuhua Li et al.|The Lancet|2016Cited by 202
Comprehensive Clinical and Laboratory Follow-up of a Female Patient With Ebola Virus Disease: Sierra Leone Ebola Virus Persistence StudyWilliam J. Liu, Tina Davies, Foday Sesay et al.|Open Forum Infectious Diseases|2019Cited by 17